Compositions and associated methods for radioisotope-binding microparticles
AssigneeBiosphere Medical, Inc.
InventorsPhilippe Reb, Celine Chaix
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to polymeric materials that may be labeled with a radioisotope, to processes for producing the labeled polymeric material, and to methods of using the materials in analytical and therapeutic applications. Specifically, the disclosure relates to injectable and implantable microparticles, such as microspheres, which are associated with radioisotopes such that the microparticles are both therapeutic and detectable. The radioisotope-containing microparticles are useful for embolization and other therapeutic medical applications.
Claims22
A microparticle, comprising a polymer having a diameter ranging from about 1 micrometer to about 2000 micrometer, the polymer comprising at least one type of polymerized monomer and a chelating agent, the chelating agent configured to chelate a radioisotope.
A microparticle of Formula II:
- P—X-M (Formula II)
- wherein P is a polymer comprising polymerized monomers selected from at least one of the following:
- acrylates, acrylamides, acrylics, vinyls, acetals, allyls, cellulosics, methacrylates, polyamides, polycarbonates, polyesters, polyimides, polyolefins, polyphosphates, polyurethanes, silicones, styrenics, and polysaccharides;
- wherein X represents Y—Z,
- wherein Z is a chelating group selected from at least one of the following:
- mercaptoacetyltriglycine;
- a mercaptoacetyltriglycine derivative;
- EDTA;
- an EDTA derivative including EGTA, BAPTA, DOTA, DTPA-monoamide, DO3A, NOTA-Bn, NODASA, and NODAGA;
- a crown ether, iminodiacetic acid;
- styrene;
- butyl acrylate;
- glycidyl methacrylate;
- aminocarboxylic acids such as alkylenediamine-N,N,N′, N′-tetraacetic acid-(meth)acrylamide (MAM-EDTA);
- acrylic acid;
- butyl methacrylate;
- bromomethyl acrylate;
- α-chloromethacryloyl chloride;
- isonicotinyl hydrazone;
- 2-methacryloxy-5-methyl benzophenone;
- pyridoxal isonicotinyl hydrazone;
- peptides;
- oligomers;
- amino acids;
- phosphorodiamidate morpholino oligomers;
- dimercaptosuccinic acids;
- pentetic acid;
- hydroxyethylidine diphosphonate;
- 4-hexadecyl-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol (HDD);
- an ethyl cysteinate dimer/lipiodol mixture;
- and a bis(diethyldithiocarbamato)nitrido (DEDC) chelator;
- wherein Y comprises a chain of between 1-18 non-hydrogen atoms independently selected from at least one of C, N, O or S;
- and
- wherein M is a radioisotope.
Dependencies are inferred from the claim text.